Safety and Tolerability of COVID-19 Vaccine (ABNCoV2)

NCT04839146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Severe Acute Respiratory Syndrome
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: ABNCoV2 Vaccine

Sponsor

Radboud University Medical Center

Collaborators

[object Object]